Unknown

Dataset Information

0

Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function.


ABSTRACT: Plasmacytoid dendritic cells (pDC) are essential for immune competence. Here we show that pDC precursor differentiated from human CD34+ hematopoietic stem and progenitor cells (HSPC) has low surface expression of pDC markers, and has limited induction of type I interferon (IFN) and IL-6 upon TLR7 and TLR9 agonists treatment; by contrast, cGAS or RIG-I agonists-mediated activation is not altered. Importantly, after priming with type I and II IFN, these precursor pDCs attain a phenotype and functional activity similar to that of peripheral blood-derived pDCs. Data from CRISPR/Cas9-mediated genome editing of HSPCs further show that HSPC-pDCs with genetic modifications can be obtained, and that expression of the IFN-? receptor is essential for the optimal function, but dispensable for the differentiation, of HSPC-pDC percursor. Our results thus demonstrate the biological effects of IFNs for regulating pDC function, and provide the means of generating of gene-modified human pDCs.

SUBMITTER: Laustsen A 

PROVIDER: S-EPMC6117296 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function.

Laustsen A A   Bak R O RO   Krapp C C   Kjær L L   Egedahl J H JH   Petersen C C CC   Pillai S S   Tang H Q HQ   Uldbjerg N N   Porteus M M   Roan N R NR   Nyegaard M M   Nyegaard M M   Denton P W PW   Jakobsen M R MR  

Nature communications 20180830 1


Plasmacytoid dendritic cells (pDC) are essential for immune competence. Here we show that pDC precursor differentiated from human CD34<sup>+</sup> hematopoietic stem and progenitor cells (HSPC) has low surface expression of pDC markers, and has limited induction of type I interferon (IFN) and IL-6 upon TLR7 and TLR9 agonists treatment; by contrast, cGAS or RIG-I agonists-mediated activation is not altered. Importantly, after priming with type I and II IFN, these precursor pDCs attain a phenotype  ...[more]

Similar Datasets

| S-EPMC3725256 | biostudies-other
| S-EPMC6237916 | biostudies-literature
| S-EPMC8391167 | biostudies-literature
| S-EPMC2892243 | biostudies-literature
| S-EPMC7502826 | biostudies-literature
| S-EPMC3907389 | biostudies-literature
| S-EPMC8428867 | biostudies-literature
| S-EPMC7453765 | biostudies-literature
| S-EPMC10133850 | biostudies-literature
2020-09-14 | PXD019239 | Pride